United States

People: Mesoblast Ltd (MSB.AX)

MSB.AX on Australia Stock Exchange

21 Jul 2017
Change (% chg)

$-0.05 (-2.76%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Spooner, Michael 

Mr. Michael R. Spooner is an Non-Executive Independent Director of Mesoblast Ltd. During this period he has filled various roles including as Chairman from the date of the ASX public listing in 2004 until 2007, Chair of the Audit and Risk Committee as well as a member of the Remuneration Committee. Over the past several years Mr Spooner has served on the Board of Directors in various capacities at several Australian and international biotechnology companies, including BiVacor Pty Ltd (2009-2013), Advanced Surgical Design & Manufacture Limited (2010-2011), Peplin, Inc. (2004-2009), Hawaii Biotech, Inc. (2010-2012), Hunter Immunology Limited (2007-2008), and Ventracor Limited (2001-2003). Prior to returning to Australia in 2001, he spent much of his career internationally where he served in various roles including as a partner to PA Consulting Group, a United Kingdom-based management consultancy and a Principal Partner and Director of Consulting Services with PricewaterhouseCoopers (Coopers & Lybrand) in Hong Kong. In addition, Mr Spooner has owned and operated several international companies providing services and has consulted to a number of American and Asian public companies.

Basic Compensation

Total Annual Compensation, AUD 163,250
Restricted Stock Awards, AUD --
Long-Term Incentive Plans, AUD --
All Other, AUD 15,509
Fiscal Year Total, AUD 178,759

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --